Discussing longevity insights among financial and biotech leaders from at the BioFuture Conference, Juvena CEO, Hanadie Yousef, PhD explores the role of secreted proteins in targeting chronic and age-related diseases.
Juvena Therapeutics is recognized for its transformative science that targets unmet medical needs as well as for the quality of its management team as part of the Emerging Company Showcase at the prestigious Life Sciences Summit.
BioCom California, the leading life science industry organization in California recognizes Juvena’s CEO, Dr. Hanadie Yousef for her achievements, vision and scientific and business accumen in its Life Science Catalyst Awards.
Juvena CEO, Hanadie Yousef, PhD, discusses the market opportunity for their unique discovery platform for mapping secreted proteins to unmet medical needs leading to their growing pipeline of biologics for rare and chronic diseases to senior leaders of Mubadala’s LP.
To help drive change in biotech, Dr. Hanadie Yousef joined the industry’s leading women CEOs and investors at the first joint Women Investors and CEOs networking event hosted by Sofinnova Investments and Cowen. Together these women are driven to create positive change in the industry, improving diversity among biotech c-suite and investors and supporting one another.
Horizon Ventures Techcracker conference spotlights Juvena Co-Founder, Hanadie Yousef, PhD as one of 70 founders of innovative new companies developing disruptive technologies that improve lives Oct. 2022
At the Myotonic Dystrophy Foundation Annual conference Juvena Therapeutics joins a community of advocates, people who suffer from this most common muscular dystrophy, their families, caregivers, clinical leaders and experts, and Industry leaders developing therapeutics for this major unmet medical need Sept. 2022
The Ending Age-Related Diseases Conference Featured Juvena CEO and CO-Founder, Hanadie Yousef, PhD, as a leading aging biology expert discussing “Building a Pipeline of Therapeutics that Target Diseases of Aging” and Dr. Thach Mai, leading Discovery Scientist, discussing Juvena’s innovative ML-enhanced platform for protein drug discovery Aug. 2022
